Document is current
Any future updates will be listed below
-
Authors
Kaleem, Safa
Callaway, Cali C. M.
Kamel, Hooman
Poyraz, Fernanda Carvalho
Ch’ang, Judy H.
- License Information
-
More Information
Article History
Accepted: 13 June 2025
First Online: 28 June 2025
Declarations
:
: H.K. has a PI role in the ARCADIA trial, which received in-kind study drug from the BMS-Pfizer Alliance for Eliquis and ancillary study support from Roche Diagnostics; a Deputy Editor role for JAMA Neurology; clinical trial steering/executive committee roles for the STROKE-AF (Medtronic), LIBREXIA-AF (Janssen), and LAAOS-4 (Boston Scientific) trials; consulting or endpoint adjudication committee roles for AbbVie, Alnylam, Arthrosi Therapeutics, AstraZeneca, Boehringer Ingelheim, Eli Lilly, and Novo Nordisk; and household ownership interests in TETMedical, Spectrum Plastics Group, and Ascential Technologies.J.C. receives payments from Swoop Hyperfine for consultations.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
